Microbot Medical Inc. [NASDAQ: MBOT] shares surged 6% during the pre-market trading session of Wednesday. The positive performance of the firm’s stock comes after the firm disclosed that United States Patent and Trade Office (USPTO) has awarded a Notice of Allowance including the Company’s LIBERTY Robotic System.
This greatest accomplishment will further help the firm to establish a competitive advantage and survive the difficulties of the market. The firm disclosed that this IP enables the firm to safeguard its assets all around the world and made progress towards commercialization. Presently, MBOT has owned 45 patents issued/allowed and 24 pending patent applications all around the world.
The allowed patent related to a device for automatically inserting and controlling a medical tool into and within a bodily lumen. The allowed claims encompass a compact robotic drive for driving and controlling the movement of at least one elongate surgical tool.
Furthermore, the firm believed that its advanced technology is in a unique position to revolutionize catheter-based procedures and benefit more sufferers all around the world while keeping physicians safe from radiation and reducing their physical strain.